Physician profile
Ariel H Freeman
NPI 1477989275
$4,393.71
in general payments reported to CMS, 2019-2025
33 companies · $1,183 in 2025
The $1,183 reported for 2025 was more than what 88% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $200 · 2022: $169 · 2023: $1,433 · 2024: $1,409 · 2025: $1,183.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,799 · Education: $185 · Travel and Lodging: $41.30.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,798.84 |
| Education | $184.50 |
| Travel and Lodging | $41.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $714.07 | 2024-2025 | Lifevest |
| Boston Scientific Corporation | $405.16 | 2023-2025 | Watchman Flx, Watchman Access System, Lux-Dx Insertable Cardiac Monitor |
| Novartis Pharmaceuticals Corporation | $326.31 | 2021-2025 | |
| Heartflow, INC. | $325.02 | 2023-2025 | Ffrct |
| Abbott Laboratories | $301.18 | 2021-2023 | Ensite Precision, Cardiomems, Mitraclip |
| Medtronic, INC. | $262.21 | 2023-2024 | Mycarelink, Na, Ffrangio |
| E.R. Squibb & Sons, L.L.C. | $234.33 | 2022-2025 | Camzyos, Eliquis |
| Astrazeneca Pharmaceuticals LP | $175.85 | 2021-2024 | Farxiga, Lokelma |
| Pfizer INC. | $171.46 | 2021-2025 | |
| Philips North America LLC | $167.16 | 2023-2024 | (5044) Mcot, (5050) Extended Holter |
| Atricure, INC. | $121.16 | 2022-2025 | Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System, Synergy Ablation System |
| Merck Sharp & Dohme LLC | $115.78 | 2022-2025 | Verquvo |
| Scpharmaceuticals INC. | $105.67 | 2023-2025 | |
| Biosense Webster, INC. | $93.18 | 2023-2025 | Carto 3, Nuvision Ice Catheter |
| Abiomed | $84.04 | 2024 | Impella |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $83.76 | 2022-2025 | Repatha, Repatha |
| Cvrx, INC. | $79.86 | 2025 | Barostim Neo System |
| Sanofi-Aventis U.S. LLC | $75.05 | 2021-2023 | |
| Novo Nordisk INC | $64.49 | 2023-2025 | Wegovy, Rybelsus, Ozempic |
| Janssen Pharmaceuticals, INC | $61.99 | 2021-2023 | Xarelto |
| Irhythm Technologies, INC. | $52.28 | 2023 | Zio Xt Patch |
| Lilly USA, LLC | $51.84 | 2025 | Zepbound |
| Cardiva Medical, INC. | $49.67 | 2023-2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Alnylam Pharmaceuticals INC. | $44.44 | 2024-2025 | Onpattro |
| Regeneron Healthcare Solutions, INC. | $43.60 | 2023-2024 | Evkeeza |
| Impulse Dynamics (USA) INC. | $39.36 | 2023 | Optimizer |
| Boehringer Ingelheim Pharmaceuticals, INC. | $38.53 | 2022-2023 | Jardiance |
| Actelion Pharmaceuticals US, INC. | $22.83 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $19.93 | 2023 | Inpefa |
| Edwards Lifesciences Corporation | $18.99 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Amarin Pharma, INC. | $17.81 | 2022 | |
| Inspire Medical Systems, INC. | $15.42 | 2024 | Inspire |
| Kowa Pharmaceuticals America, INC. | $11.28 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ariel Freeman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.